A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: A phase II double-blind, randomized placebo-controlled study

Clinical and Investigative Medicine

Volumn 35, Issue 1, 2012, Pages

  Chen, Hong Wen ^a,b   Lin, I Hsin ^c   Chen, Yu Jen ^a   Chang, Kao Hwa ^a,d   Wu, Meng Hao ^a   Su, Wen Hao ^a,b   Huang, Gwo Che ^a   Lai, Yuen Liang ^a,e,f  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c Taichung Hospital Department of Health   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

AGED; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PHASE 2 CLINICAL TRIAL; PLANT; RANDOMIZED CONTROLLED TRIAL;

AGED; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLACEBOS; PLANTS;

EID: 84861316948     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. National Comprehensive Cancer Network, Inc: WHO Definition of Palliative Care, World Health Organization. NCCN Clinical Practice Guidelines in Oncology™: Cancer related fatigue Version 1. 2010 Jan 22. [http://www.nccn.org]
2. Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliative Medicine 2009; 23: 325-331.
3. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. National Comprehensive Cancer Network fatigue guidelines. Oncology (Williston Park) 2000; 14: 151-161.
4. Jean-Pierre P, Figueora-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 2007, 12, 11-21
5. Breitbart W, Alici Y. Pharmacologic treatment options for cancer-related fatigue: current state of clinical research. Clin J Oncol Nurs 2008, 12, 11-20
6. Molassiotis A, Potrata B, Cheng KKF. A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complement Ther Med 2009, 17, 92-120
7. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor
8. Effect of Astragalus injection combined with chemotherapy on quality of life in patients with advanced nonsmall cell lung cancer
9. Effect of Astragalus polysaccharide in stimulating the secretion of hematopoietic growth factors from activated human PBMC
10. Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM: A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 2004, 320, 4, 1103-11
11. Wang YF, Yang XF, Cheng B, Mei CL, Li QX, Xiao H, Zeng QT, Liao YH, Liu K. Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha. Phytother Res. 2010, 24, 3, 393-8.
12. Lin CC, Chang A, Chen M, Cleeland CS, Mendoza TR, Wang XS. Validation of the Taiwanese Version of the Brief Fatigue Inventory. J Pain Symptom Manage 2006, 32, 52-59
13. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL: the rapid assessment of fatigue severity in cancer patients. Cancer 1999, 85, 1186-1196.
14. Roth AJ, Nelson C, Rosenfeld B, Scher H, Slovin S, Morris M, O'Shea N, Arauz G, Breitbart W: Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer 2010, 116, 21, 5102-10.
15. Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K: Management of cancer-related fatigue. Cancer Invest 2005, 23, 229-239
16. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Gri-n PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial. J Clin Oncol 2010, 28, 23, 3673-9.
17. Lower EE, Fleishman S, Cooper A, Zeldis J Faleck H, Yu Z, Manning D: Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 2009, 38, 5, 650-662
18. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R: Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985, 69, 751-754
19. Chui YY, Donoghue J, Chenoweth L: Responses to advanced cancer: Chinese-Australians. J Adv Nurs 2005, 52, 5, 498-507
20. Mills S, Bone K. Principles and Practice of Phytotherapy. Edinburgh, Scotland, Churchill Livingstone, 2000
21. Wei H, Sun R, Xiao, W.; Feng, J.; Zhen, C.; Xu, X.; Tian, Z. Traditional Chinese medicine Astragalus reverses predominance of th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncol Rep 2003, 10, 1507-1512
22. McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM Jr. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced nonsmall-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006, 24, 419-30
23. Block KI, Mead MN. Immune system effects of Echinacea, Ginseng and Astragulus: A Review. Integrative Cancer therapies 2003, 2, 3, 247-267
24. Kurzrock R. the role of cytokines in cancer-related fatigue. Cancer 2001, 92, 6, 1684-8
25. Patarca R, Mark T, Fletcher MA, Klimas N. Review: Immunology of Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome 2000, 6, 3/4, 69-107
26. Steensma, DP, Molina, R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KMJr, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol 2006, 24, 1079-1089
27. de la Cruz M, Hui D, Parsons HA, Bruera E. Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 2010, 116, 3, 766-74
28. Bruera E, El Osta B, Valero V, Driver LC, Pei BL, Shen L, Poulter VA, Palmer JL. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2007, 25, 23, 3475-3481
29. Morita T, Miyashita M, Shibagaki M, Hirai K, Ashiya T, Ishihara T, Matsubara T.; Miyoshi I, Nakaho T, Nakashima N, Onishi H, Ozawa T, Suenaga K, Tajima T, Akechi T, Uchitomi Y. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage 2006, 31, 4, 306-316